4//SEC Filing
Burnett Patrick 4
Accession 0001741987-25-000005
CIK 0001787306other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 6:57 PM ET
Size
9.2 KB
Accession
0001741987-25-000005
Insider Transaction Report
Form 4
Burnett Patrick
See Remarks
Transactions
- Sale
Common Stock
2025-11-03$25.40/sh−15$381→ 102,189 total - Sale
Common Stock
2025-11-03$24.71/sh−2,607$64,425→ 102,204 total - Sale
Common Stock
2025-11-05$23.72/sh−3,864$91,643→ 98,325 total
Footnotes (4)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.31 to $25.31, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026.
- [F4]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $23.52 to $23.865, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001741987
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 6:57 PM ET
- Size
- 9.2 KB